Maritsch, Friedrich
Cil, Ingeborg
McKinnon, Colin
Potash, Jesse
Baumgartner, Nicole
Philippon, Valérie
Pavlova, Borislava G.
Article History
Received: 9 March 2022
Accepted: 15 June 2022
First Online: 25 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: FM is a consultant for Takeda’s Clinical Trial Transparency Dept. at Baxalta Innovations GmbH, a Takeda company. IC was an employee of Baxalta Innovations GmbH, a Takeda company, at the time the analyses were performed; she is currently an advisor to Takeda’s Clinical Trial Transparency Dept. CMK is an employee of Takeda Pharmaceuticals International AG and owns stock in Takeda. JP is an employee of Takeda Development Center Americas Inc. and owns stock in Takeda. NB is a consultant for Takeda’s Clinical Trial Transparency Dept. at Baxalta Innovations GmbH, a Takeda company. VP is an employee of Takeda Development Center Americas Inc. and owns stock in Takeda. BGP is an employee of Baxalta Innovations GmbH, a Takeda company, and owns stock in Takeda.